Diamond Biofund Statistics
Total Valuation
Diamond Biofund has a market cap or net worth of TWD 10.97 billion. The enterprise value is 4.44 billion.
Important Dates
The last earnings date was Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Diamond Biofund has 853.36 million shares outstanding. The number of shares has increased by 1.62% in one year.
| Current Share Class | 853.36M |
| Shares Outstanding | 853.36M |
| Shares Change (YoY) | +1.62% |
| Shares Change (QoQ) | -1.29% |
| Owned by Insiders (%) | 25.00% |
| Owned by Institutions (%) | 4.41% |
| Float | 177.01M |
Valuation Ratios
The trailing PE ratio is 4.54.
| PE Ratio | 4.54 |
| Forward PE | n/a |
| PS Ratio | 4.28 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 1.81 |
| EV / Sales | 1.73 |
| EV / EBITDA | 1.82 |
| EV / EBIT | 1.84 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 86.18, with a Debt / Equity ratio of 0.01.
| Current Ratio | 86.18 |
| Quick Ratio | 86.14 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 977.97 |
Financial Efficiency
Return on equity (ROE) is 23.42% and return on invested capital (ROIC) is 46.69%.
| Return on Equity (ROE) | 23.42% |
| Return on Assets (ROA) | 14.22% |
| Return on Invested Capital (ROIC) | 46.69% |
| Return on Capital Employed (ROCE) | 20.54% |
| Weighted Average Cost of Capital (WACC) | 9.15% |
| Revenue Per Employee | 88.33M |
| Profits Per Employee | 84.48M |
| Employee Count | 29 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.05% in the last 52 weeks. The beta is 0.90, so Diamond Biofund's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -23.05% |
| 50-Day Moving Average | 15.76 |
| 200-Day Moving Average | 15.78 |
| Relative Strength Index (RSI) | 26.02 |
| Average Volume (20 Days) | 1,465,035 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Diamond Biofund had revenue of TWD 2.56 billion and earned 2.45 billion in profits. Earnings per share was 2.83.
| Revenue | 2.56B |
| Gross Profit | 2.56B |
| Operating Income | 2.41B |
| Pretax Income | 2.45B |
| Net Income | 2.45B |
| EBITDA | 2.42B |
| EBIT | 2.41B |
| Earnings Per Share (EPS) | 2.83 |
Full Income Statement Balance Sheet
The company has 6.60 billion in cash and 75.54 million in debt, with a net cash position of 6.53 billion or 7.65 per share.
| Cash & Cash Equivalents | 6.60B |
| Total Debt | 75.54M |
| Net Cash | 6.53B |
| Net Cash Per Share | 7.65 |
| Equity (Book Value) | 11.70B |
| Book Value Per Share | 13.63 |
| Working Capital | 6.55B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -577.81 million and capital expenditures -1,000, giving a free cash flow of -577.81 million.
| Operating Cash Flow | -577.81M |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 5.43M |
| Net Borrowing | -24.44M |
| Free Cash Flow | -577.81M |
| FCF Per Share | -0.68 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of 94.22% and 95.64%.
| Gross Margin | 100.00% |
| Operating Margin | 94.22% |
| Pretax Margin | 95.64% |
| Profit Margin | 95.64% |
| EBITDA Margin | 94.43% |
| EBIT Margin | 94.22% |
| FCF Margin | n/a |
Dividends & Yields
Diamond Biofund does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.62% |
| Shareholder Yield | -1.62% |
| Earnings Yield | 22.02% |
| FCF Yield | -5.27% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.18.
| Last Split Date | Aug 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.18 |
Scores
Diamond Biofund has an Altman Z-Score of 66.93 and a Piotroski F-Score of 3.
| Altman Z-Score | 66.93 |
| Piotroski F-Score | 3 |